Ajanta Pharma
- All
- News
- Videos
-
Ajanta Pharma Gains 4% After Board Approves Rs 286-Crore Share Buyback Plan
Ajanta Pharma Share Price: On Tuesday, shares of Ajanta Pharma settled 3.83 per cent higher at Rs 2,263.90 apiece on the BSE.
-
Stocks To Watch: Coal India, Dr Reddy's Labs, Auto Shares In Focus Today
List of Stocks in Focus Today: Auto companies, including Tata Motors, Hero MotoCorp and Eicher Motors, are set to hog the limelight on the bourses after reporting stellar sales performance for the month of November
-
Trading Calls: Buy Ajanta Pharma, Axis Bank, Tata Motors DVR, Say Experts
Indian equity markets are likely to open lower on Friday tracking geopolitical tensions.
-
Ajanta Pharma Launches Pain Relief Tablets In US
Shares of Ajanta Pharma were trading 0.35 per cent higher at Rs 1,197.10 on the BSE.
-
Indian Drugmakers Face Squeeze In US Healthcare Market
Consolidation among U.S. drugs distributors and a federal investigation into drug pricing have also reduced the pricing power of drugsmakers.
-
Ugandan PM Visits India; Plans To Invest USD 100 Million
Uganda Prime Minister Ruhakana Rugunda will sign letters of intent worth USD 100 million to boost bilateral trade with India.
-
Ajanta Pharma Gets USFDA Observation For Paithan Facility
Drug firm Ajanta Pharma on Thursday said the US health regulator has issued one observation for its Paithan facility in Aurangabad after the inspection.
-
Ajanta Pharma Denies Alert From USFDA, Shares Fall
There were media reports saying the company has got import alert from USFDA for its Paithan unit at Aurangabad for which BSE had sought for a clarification from Ajanta Pharma.
-
Ajanta Pharma Launches Blood Pressure Lowering Tablets In US
The product has been launched in four strengths 5mg20mg, 5mg40mg, 10mg20mg and 10mg40mg, Ajanta Pharma said.
-
Ajanta Pharma Guwahati Facility To Be Ready By March
With substantial investments of Rs 106 crore in R&D in 2015-16, use of latest platform technologies and developing niche and complex formulations, Ajanta Pharma is confident of reinforcing its exclusive positioning in the markets it operates in.
-
Buy Or Sell: Stock Recommendations From Market Experts
Markets were trading on a subdued note in trades today tracking weakness in other Asian markets. Here are top trading calls for today.
-
Ajanta Pharma Promoters To Consolidate Shareholding
Ajanta Pharma's promoters haveagreed to consolidate their shareholding in the hands of sevenfamily members and one family-controlled promoter group entityin order to give better visibility to the investors.
-
Ajanta Pharma Gets USFDA Nod For Generic Acid Reflux Drug
Ajanta Pharma has received nod from the US health regulator for generic Omeprazole and sodium bicarbonate powder for oral suspension used for treatment of stomach and esophagus problems such as ulcers and acid reflux.
-
Ajanta Pharma Posts 39% Rise In Q1 Profit
Drug firm Ajanta Pharma has reported a 38.99 per cent rise in consolidated net profit at Rs 119.55 crore for the quarter ended June 30, 2016, mainly on robust sales.
-
Ajanta Pharma Launches Acid Reflux Drug In US
Ajanta Pharma has launched generic omeprazole and sodium bicarbonate capsules, used in the treatment of acid reflux and ulcers, in the American market after receiving final approval from the US Food and Drug Administration (FDA).
-
Ajanta Pharma Gains 4% After Board Approves Rs 286-Crore Share Buyback Plan
Ajanta Pharma Share Price: On Tuesday, shares of Ajanta Pharma settled 3.83 per cent higher at Rs 2,263.90 apiece on the BSE.
-
Stocks To Watch: Coal India, Dr Reddy's Labs, Auto Shares In Focus Today
List of Stocks in Focus Today: Auto companies, including Tata Motors, Hero MotoCorp and Eicher Motors, are set to hog the limelight on the bourses after reporting stellar sales performance for the month of November
-
Trading Calls: Buy Ajanta Pharma, Axis Bank, Tata Motors DVR, Say Experts
Indian equity markets are likely to open lower on Friday tracking geopolitical tensions.
-
Ajanta Pharma Launches Pain Relief Tablets In US
Shares of Ajanta Pharma were trading 0.35 per cent higher at Rs 1,197.10 on the BSE.
-
Indian Drugmakers Face Squeeze In US Healthcare Market
Consolidation among U.S. drugs distributors and a federal investigation into drug pricing have also reduced the pricing power of drugsmakers.
-
Ugandan PM Visits India; Plans To Invest USD 100 Million
Uganda Prime Minister Ruhakana Rugunda will sign letters of intent worth USD 100 million to boost bilateral trade with India.
-
Ajanta Pharma Gets USFDA Observation For Paithan Facility
Drug firm Ajanta Pharma on Thursday said the US health regulator has issued one observation for its Paithan facility in Aurangabad after the inspection.
-
Ajanta Pharma Denies Alert From USFDA, Shares Fall
There were media reports saying the company has got import alert from USFDA for its Paithan unit at Aurangabad for which BSE had sought for a clarification from Ajanta Pharma.
-
Ajanta Pharma Launches Blood Pressure Lowering Tablets In US
The product has been launched in four strengths 5mg20mg, 5mg40mg, 10mg20mg and 10mg40mg, Ajanta Pharma said.
-
Ajanta Pharma Guwahati Facility To Be Ready By March
With substantial investments of Rs 106 crore in R&D in 2015-16, use of latest platform technologies and developing niche and complex formulations, Ajanta Pharma is confident of reinforcing its exclusive positioning in the markets it operates in.
-
Buy Or Sell: Stock Recommendations From Market Experts
Markets were trading on a subdued note in trades today tracking weakness in other Asian markets. Here are top trading calls for today.
-
Ajanta Pharma Promoters To Consolidate Shareholding
Ajanta Pharma's promoters haveagreed to consolidate their shareholding in the hands of sevenfamily members and one family-controlled promoter group entityin order to give better visibility to the investors.
-
Ajanta Pharma Gets USFDA Nod For Generic Acid Reflux Drug
Ajanta Pharma has received nod from the US health regulator for generic Omeprazole and sodium bicarbonate powder for oral suspension used for treatment of stomach and esophagus problems such as ulcers and acid reflux.
-
Ajanta Pharma Posts 39% Rise In Q1 Profit
Drug firm Ajanta Pharma has reported a 38.99 per cent rise in consolidated net profit at Rs 119.55 crore for the quarter ended June 30, 2016, mainly on robust sales.
-
Ajanta Pharma Launches Acid Reflux Drug In US
Ajanta Pharma has launched generic omeprazole and sodium bicarbonate capsules, used in the treatment of acid reflux and ulcers, in the American market after receiving final approval from the US Food and Drug Administration (FDA).
